SI
AGN

Scharf Investments’s Allergan plc AGN Stock Holding History

Scharf Investments’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-77,196
Closed -$13.7M – 48
2020
Q1 		$13.7M Sell
77,196
-622,118
-89% -$117M 0.68% 25
2019
Q4 		$134M Sell
699,314
-6,992
-1% -$1.26M 5.23% 7
2019
Q3 		$119M Sell
706,306
-1,417
-0.2% -$231K 4.85% 7
2019
Q2 		$118M Sell
707,723
-66,920
-9% -$9.27M 4.67% 9
2019
Q1 		$113M Buy
774,643
+45,697
+6% +$6.63M 4.37% 13
2018
Q4 		$97.4M Buy
728,946
+146,937
+25% +$24.1M 3.87% 13
2018
Q3 		$111M Sell
582,009
-55,020
-9% -$10.1M 3.86% 14
2018
Q2 		$106M Sell
637,029
-132,531
-17% -$21.3M 3.79% 14
2018
Q1 		$130M Sell
769,560
-2,554
-0.3% -$428K 3.64% 14
2017
Q4 		$126M Sell
772,114
-117,145
-13% -$21M 2.87% 18
2017
Q3 		$182M Buy
889,259
+12,862
+1% +$2.99M 4.42% 10
2017
Q2 		$213M Buy
876,397
+63,893
+8% +$15M 5% 5
2017
Q1 		$194M Buy
812,504
+4,105
+0.5% +$956K 4.64% 8
2016
Q4 		$170M Sell
808,399
-43,251
-5% -$8.96M 3.94% 11
2016
Q3 		$196M Sell
851,650
-9,388
-1% -$2.29M 4.55% 12
2016
Q2 		$199M Buy
861,038
+163,179
+23% +$37.6M 4.47% 11
2016
Q1 		$187M Sell
697,859
-68,421
-9% -$19.6M 4.35% 13
2015
Q4 		$239M Buy
766,280
+316,277
+70% +$94.2M 5.71% 2
2015
Q3 		$122M Buy
450,003
+54,684
+14% +$16.8M 3.21% 18
2015
Q2 		$120M Buy
395,319
+18,105
+5% +$5.4M 3.08% 19
2015
Q1 		$112M Buy
+377,214
New +$108M 3.11% 17

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Scharf Investments's AGN Position: Q2 2020 in Review

Scharf Investments sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 77,196 shares — an estimated $13.7M sold.

Scharf Investments first reported a position in AGN in Q1 2015 and held it in 21 quarters. The position peaked at $239M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Scharf Investments reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Scharf Investments sold 77,196 Allergan plc shares in Q2 2020, an estimated $13.7M.
  • Scharf Investments first reported a position in Allergan plc in Q1 2015 and held it in 21 quarters.
  • Scharf Investments's Allergan plc position peaked at $239M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Scharf Investments's 13F filing for Q2 2020, filed 16 Jul 2020.